LONDON, July 9 (Reuters) - GlaxoSmithKline Plc has won a licence extension in Europe for Seretide, allowing its top-selling inhaler product to be used in a wider population of patients with the lung ...
Faulty inhalers could be putting thousands of lives at risk as an urgent recall has been issued. Two different brands of inhalers have been recalled over fears they not be correctly delivering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback